Azilsartan Medoxomil is an angiotensin II receptor antagonist used in the treatment of hypertension, developed by Takeda. It is marketed in tablet form under the brand name Edarbi as the prodrug azilsartan medoxomi. Reference standards of Azilsartan Medoxomil API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Azilsartan medoxomil
Catalogue No.:PA 01 2910000
CAS :
Molecular Formula : C30H24N4O8
Molecular Weight : 568.54
2-Ethoxy-1H-1,3-benzodiazole-7-carboxylic Acid
Catalogue No.:PA 01 2911000
Molecular Formula : C10H10N2O3
Molecular Weight : 206.2
1-((2'-(1H-Diazirin-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic Acid
Catalogue No.:PA 01 2911001
Molecular Formula : C24H20N4O3
Molecular Weight : 412.45
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(5-(2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazol-7-yl)-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
Catalogue No.:PA 01 2911002
Molecular Formula : C54H42N8O10
Molecular Weight : 962.98
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
